Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain [Yahoo! Finance]
Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.auriniapharma.com
Company Research
Source: Yahoo! Finance
If you are looking at Aurinia Pharmaceuticals and wondering whether the current share price reflects its true value, this article will walk you through what the numbers actually say about the stock. The share price closed at US$13.95 recently, with a 71.0% return over the past year but softer moves in the near term, including a 2.6% decline over 7 days and a 2.0% decline over 30 days, alongside a 9.1% decline year to date and a 46.7% return over 3 years. Recent headlines around Aurinia Pharmaceuticals have focused on ongoing interest in its drug portfolio and business outlook. This helps explain why the share price has been more volatile over shorter periods. As investors react to these updates, the key question is whether this recent performance lines up with what the company might be worth based on fundamentals. Aurinia Pharmaceuticals currently scores a 6 out of 6 valuation score . We will look at how different valuation approaches arrive at that view, and then finish by sha
Show less
Read more
Impact Snapshot
Event Time:
AUPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUPH alerts
High impacting Aurinia Pharmaceuticals Inc - Common Shares news events
Weekly update
A roundup of the hottest topics
AUPH
News
- MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition [Yahoo! Finance]Yahoo! Finance
- MKT Capital Applauds Aurinia Pharmaceuticals’ Management TransitionBusiness Wire
- Aurinia Announces Management TransitionBusiness Wire
- Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade) [Seeking Alpha]Seeking Alpha
- Spherix Global Insights Finds Benlysta Exposure Expanding and Rheumatologists Increasingly Turning to Lupkynis in Lupus Nephritis [Yahoo! Finance]Yahoo! Finance
AUPH
Earnings
- 2/26/26 - Beat
AUPH
Sec Filings
- 3/25/26 - Form SCHEDULE
- 3/23/26 - Form 8-K
- 3/10/26 - Form 4
- AUPH's page on the SEC website